Abstract
Entry of HIV-1 into target cells requires cell-surface CD4 and additional host cell cofactors. A cofactor required for infection with virus adapted for growth in transformed T-cell lines was recently identified and named fusin. However, fusin does not promote entry of macrophage-tropic viruses, which are believed to be the key pathogenic strains in vivo. The principal cofactor for entry mediated by the envelope glycoproteins of primary macrophage-tropic strains of HIV-1 is CC-CKR-5, a receptor for the β-chemokines RANTES, MIP-1α and MIP-1β.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection
Retrovirology Open Access 10 August 2022
-
A functional map of HIV-host interactions in primary human T cells
Nature Communications Open Access 01 April 2022
-
Co-receptor signaling in the pathogenesis of neuroHIV
Retrovirology Open Access 24 August 2021
Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Sattentau, Q. J. & Weiss, R. A. Cell 52, 631–633 (1988).
Maddon, P. J. et al. Cell 47, 333–348 (1986).
Ashorn, P. A., Berger, E. A. & Moss, B. J. Virol. 64, 2149–2156 (1990).
Page, K. A., Landau, N. R. & Littman, D. R. J. Virol. 64, 5270–5276 (1990).
Gartner, S. et al. Science 233, 215–219 (1986).
Koyanagi, Y. et al. Science 236, 819–822 (1987).
Fisher, A. G. et al. Nature 334, 444–447 (1988).
Cheng-Mayer, C., Weiss, C., Seto, D. & Levy, J. A. Proc. natn. Acad. Sci. U.S.A. 86, 8575–8570 (1989).
Liu, Z. Q., Wood, C., Levy, J. A. & Cheng-Mayer, C. J. Virol. 64, 6148–6153 (1990).
O'Brien, W. A. et al. Nature 348, 69–73 (1990).
Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. Science 272, 872–877 (1996).
Cornelissen, M. et al. J. Virol. 69, 1810–1818 (1995).
Veenstra, J. et al. Clin. infect. Dis. 21, 556–560 (1995).
Paxton, W. A. et al. Nature Med. 2, 412–417 (1996).
Cocchi, F. et al. Science 720, 1811–1815 (1995).
Schall, T. J. Cytokine 3, 165–183 (1991).
Murphy, P. M. A. Rev. Immun. 12, 593–633 (1994).
Horuk, R. Trends pharmac. Sci. 15, 159–165 (1994).
Ben-Baruch, A. et al. J. biol. Chem. 270, 22123–22128 (1995).
Neote, K., DiGregorio, D., Mak, J. Y., Horuk, R. & Schall, T. J. Cell 72, 415–425 (1993).
Combadiere, C., Ahuja, S. K. & Murphy, P. M. J. biol. Chem. 270, 16491–16494 (1995).
Power, C. A. et al. J. biol. Chem. 270, 19495–19500 (1995).
Samson, M., Labbe, O., Mollereau, C., Vassart, G. & Parmentier, M. Biochemistry 35, 3362–3367 (1996).
Chaudhuri, A. et al. J. biol. Chem. 269, 7835–7838 (1994).
Jazin, E. E. et al. Regul. Peptides 47, 247–258 (1993).
Lusso, P. et al. J. Virol. 69, 3712–3720 (1995).
Connor, R. I., Chen, B. K., Choe, S. & Landau, N. R. Virology 206, 936–944 (1995).
Westervelt, P., Gendelman, H. E. & Ratner, L. Proc. natn. Acad. Sci. U.S.A. 88, 3097–3101 (1991).
Hwang, S. S., Boyle, T. J., Lyerly, H. K. & Cullen, B. R. Science 253, 71–74 (1991).
Landau, N. R., Page, K. A. & Littman, D. R. J. Virol. 65, 162–169 (1991).
Clapham, P. R., Blanc, D. & Weiss, R. A. Cirology 181, 703–715 (1991).
He, J. et al. J. Virol. 69, 6705–6711 (1995).
Zhu, T. et al. Science 261, 1179–1181 (1993).
Schuitemaker, H. et al. J. Virol. 66, 1354–1360 (1992).
Connor, R. I. & Ho, D. D. J. Virol. 68, 4400–4408 (1994).
De Jong, J. J., De Ronde, A., Keulen, W., Tersmette, M. & Goudsmit, J. J. Virol. 66, 6777–6780 (1992).
Fouchier, R. A. et al. J. Virol. 66, 3183–3187 (1992).
Sattentau, Q. J., Moore, J. P., Vignaux, F., Traincard, F. & Poignard, P. J. Virol. 67, 7383–7393 (1993).
Bullough, P. A., Hughson, F. M., Skehel, J. J. & Wiley, D. C. Nature 371, 37–43 (1994).
Morgenstern, J. P. & Land, H. Nucleic Acids Res. 18, 3587–3596 (1990).
Landau, N. R., Warton, M. & Littman, D. R. Nature 334, 159–162 (1988).
Gao, J. L. & Murphy, P. M. J. biol. Chem. 269, 28539–28542 (1994).
Landau, N. R. & Littman, D. R. J. Virol. 66, 5110–5113 (1992).
Pear, W. S., Nolan, G. P., Scott, M. L. & Baltimore, D. Proc. natn. Acad. Sci. U.S.A. 90, 8392–8396 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Deng, H., Liu, R., Ellmeier, W. et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661–666 (1996). https://doi.org/10.1038/381661a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/381661a0
This article is cited by
-
CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection
Retrovirology (2022)
-
A functional map of HIV-host interactions in primary human T cells
Nature Communications (2022)
-
Co-receptor signaling in the pathogenesis of neuroHIV
Retrovirology (2021)
-
Host genetics and infectious disease: new tools, insights and translational opportunities
Nature Reviews Genetics (2021)
-
Regulation and functional roles of chemokines in liver diseases
Nature Reviews Gastroenterology & Hepatology (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.